CN Patent

CN103052631B — 用于治疗副黏病毒科病毒感染的方法和化合物

Assigned to Gilead Sciences Inc · Expires 2015-11-25 · 10y expired

What this patent protects

提供了用于通过施用式(I)的核苷、其核苷磷酸盐或酯和前药来治疗副黏病毒科病毒感染的方法：其中核苷糖的1’位被取代。所提供的化合物、组合物和方法特别地可用于治疗人副流感病毒和人呼吸道合胞病毒感染。

USPTO Abstract

提供了用于通过施用式(I)的核苷、其核苷磷酸盐或酯和前药来治疗副黏病毒科病毒感染的方法：其中核苷糖的1’位被取代。所提供的化合物、组合物和方法特别地可用于治疗人副流感病毒和人呼吸道合胞病毒感染。

Drugs covered by this patent

Patent Metadata

Patent number
CN103052631B
Jurisdiction
CN
Classification
—
Expires
2015-11-25
Drug substance claim
No
Drug product claim
No
Assignee
Gilead Sciences Inc
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.